PATENT CLAIM ANALYSIS

Application Number: 16070073
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["424", "001690"]

Abstract:
There is provided a positron-emitting 18F-labelled Factor VII for non-invasive PET imaging of tumor TF expression in humans. More specifically the invention relates to human TFPET imaging of pancreatic cancer metastasis for diagnosis, staging, treatment monitoring and especially as an imaging biomarker for predicting prognosis, progression and recurrence.

Claim (Index 11):
Method according to  claim 10 , wherein FVIIai has been labelled with N-succinimidyl 4-18Ffluorobenzoate (18F-SFB) to produce:

Metadata:
- Claim Count in Document: 11.0
- Percentile: 95.0
- Lexical Diversity: 1.20455
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10512215', '13803887', '12503893', '12178126', '14230128']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7466542217504466
- 35 USC 102 Novelty (BERT): 0.5217069487773138
- Combined Prediction Score: 0.7241594944531333
- Mean Citation Score: 251.50504
- Max Citation Score: 253.4652
- Similarity Product: 128.4516149019241

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test